Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Vitale

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancers|October 23, 2021
No Need to Stick Together to Be Connected: Multiple Types of Enhancers' NetworkingEmanuele Vitale, Mila Gugnoni, Alessia Ciarrocchi
Cancer Communications (London, England)|April 22, 2022
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2Emanuele Vitale, Elisabetta Sauta, Mila Gugnoni, et al.
Frontiers in Oncology|June 28, 2024
Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapyVictoria M Valvo, Emanuele Vitale, Marco Tigano, et al.
Frontiers in Oncology|August 10, 2023
Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapyVictoria M Valvo, Emanuele Vitale, Marco Tigano, et al.
Genetics in Medicine Open|January 6, 2026
CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)Riccardo Perriera, Anabela S Ramalho, Francois Vermeulen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2022
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid CancerMila Gugnoni, Gloria Manzotti, Emanuele Vitale, et al.
IUBMB Life|June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An OverviewEmanuele Vitale, Davide Ricci, Federica Corrao, et al.
Cancers|February 25, 2023
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to DoxorubicinMargherita Cortini, Francesca Macchi, Francesca Reggiani, et al.
IUBMB Life|May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based InnovationsDavide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
Thyroid : Official Journal of the American Thyroid Association|June 5, 2020
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6Mila Gugnoni, Veronica Manicardi, Federica Torricelli, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|October 23, 2021
No Need to Stick Together to Be Connected: Multiple Types of Enhancers' NetworkingEmanuele Vitale, Mila Gugnoni, Alessia Ciarrocchi
Cancer Communications (London, England)|April 22, 2022
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2Emanuele Vitale, Elisabetta Sauta, Mila Gugnoni, et al.
Frontiers in Oncology|June 28, 2024
Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapyVictoria M Valvo, Emanuele Vitale, Marco Tigano, et al.
Frontiers in Oncology|August 10, 2023
Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapyVictoria M Valvo, Emanuele Vitale, Marco Tigano, et al.
Genetics in Medicine Open|January 6, 2026
CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)Riccardo Perriera, Anabela S Ramalho, Francois Vermeulen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2022
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid CancerMila Gugnoni, Gloria Manzotti, Emanuele Vitale, et al.
IUBMB Life|June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An OverviewEmanuele Vitale, Davide Ricci, Federica Corrao, et al.
Cancers|February 25, 2023
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to DoxorubicinMargherita Cortini, Francesca Macchi, Francesca Reggiani, et al.
IUBMB Life|May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based InnovationsDavide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
Thyroid : Official Journal of the American Thyroid Association|June 5, 2020
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6Mila Gugnoni, Veronica Manicardi, Federica Torricelli, et al.
Pageof 3